Pacific Sun Financial Corp Has $226,000 Stock Holdings in Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Pacific Sun Financial Corp cut its stake in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 13.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,740 shares of the company’s stock after selling 415 shares during the period. Pacific Sun Financial Corp owned approximately 0.08% of Invesco Pharmaceuticals ETF worth $226,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of PJP. Jane Street Group LLC acquired a new position in Invesco Pharmaceuticals ETF during the third quarter valued at $1,163,000. Arete Wealth Advisors LLC acquired a new position in Invesco Pharmaceuticals ETF during the third quarter valued at $402,000. Grimes & Company Inc. acquired a new position in Invesco Pharmaceuticals ETF during the fourth quarter valued at $354,000. JPMorgan Chase & Co. raised its position in Invesco Pharmaceuticals ETF by 241.7% during the third quarter. JPMorgan Chase & Co. now owns 4,046 shares of the company’s stock valued at $352,000 after buying an additional 2,862 shares during the period. Finally, MGB Wealth Management LLC raised its position in Invesco Pharmaceuticals ETF by 11.9% during the fourth quarter. MGB Wealth Management LLC now owns 21,976 shares of the company’s stock valued at $1,815,000 after buying an additional 2,345 shares during the period.

Invesco Pharmaceuticals ETF Stock Up 0.2 %

Shares of NYSEARCA:PJP opened at $86.61 on Thursday. The business has a 50 day moving average price of $84.30 and a 200 day moving average price of $85.86. The company has a market cap of $293.61 million, a price-to-earnings ratio of 21.48 and a beta of 0.61. Invesco Pharmaceuticals ETF has a twelve month low of $75.33 and a twelve month high of $89.87.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.